Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Induction therapy with daclizumab in cardiac transplant recipients safe and effective

March 3, 2000

U.K.'s MCA approves another new meningitis C vaccine

March 2, 2000

Celgene accelerates development of second-generation compounds from the thalidomide class

March 1, 2000

Fujisawa presents new imidazoles with inhibitory activity against adenosine deaminase

March 1, 2000

AdProTech's APT-070 shows encouraging preclinical results in transplantation

Feb. 29, 2000

Ariad's GVHD therapy receives orphan drug status

Feb. 28, 2000

PDL initiates phase I trial of SMART anti-interferon gamma antibody

Feb. 28, 2000

Aquila receives milestone payments under licensing agreements

Feb. 25, 2000

Ono claims selective EP4 receptor ligands and their use

Feb. 24, 2000

L-Nucleoside ribavirin analogues are able to enhance type 1 cytokine production

Feb. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...